Recent submissions

Comment · 1 month ago
The in-demand domains are Slovenian, just like the First Lady. What a funny coincidence!
Comment · 1 month ago
I thought force majeure is for weather catastrophes, natural disasters, terrorism, “acts of God”. Not for “we didn’t get the permits”.
Comment · 5 months ago
What does “has more weight” mean in this context?
Comment · 5 months ago
> Imfura had his little group moving constantly, an understandable method to avoid other groups and the possible transfer of his females.

> [emphasis added] But this apparently weakened their trust,

> which is essential for social cohesion.

How do the researchers know their trust was weakened by constant moving?

Comment · 7 months ago
Comment · 8 months ago
> the likelihood of attempted terror attacks against the US has increased significantly.

And one wonders if a terror attack on US soil would be the justification POTUS uses to cancel elections

Comment · 9 months ago
These type of stories are typically attributed to anonymous sources. So it’s impossible for a reader to conclude anything about the sources’ own credibility. So they usually rely on the credibility of the reporter or media org who’s published about it.

The Information is also reporting on this, but paywalled. IMO The Information does solid reporting.

https://www.theinformation.com/newsletters/applied-ai/openai...

Editing to add some of the Information’s reporting: > Speaking at a panel at Davos moderated by The Information CEO Jessica Lessin, Friar suggested that in the field of drug discovery, her company could, for instance, take a “license to the drug that is discovered” using OpenAI’s technology. In other words, OpenAI would take a profit-sharing stake in the financial upside its AI creates for customers.

> Friar is no doubt familiar with older AI drug discovery firms such as Recursion that struck deals with pharmaceutical firms to give them big bounties for successful drugs identified by their tech. There aren’t many, if any, examples of such successes yet, though.

> OpenAI isn’t the only firm eyeing this opportunity. Its rivals Anthropic, Google DeepMind and Isomorphic Labs, an Alphabet subsidiary focusing on using AI for drug discovery, have also held discussions with early-stage biotechnology startups about data licensing or partnerships.

Comment · 9 months ago
Disagree
Comment · 9 months ago
> International sanctions are restrictions on international transactions imposed by governments in pursuit of foreign policy objectives.

Imposing a restriction where one did not previously exist is quite obviously a commission.

Comment · 9 months ago
Comment · 9 months ago
If I blockade you in your house, is that failure to aid? Or something else? Sanctions occur via commission, not omission. They’re not a failure to render aid or to be maximally charitable. They’re active harm.
Comment · 9 months ago
I am saying that sanctions are weapon of sorts and have worse effects than people realize, and you seem to be saying their effects are not as bad as those of kinetic weapons. Despite Lancet concluding their tolls are comparable.

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton